SUMMARY:

  • Older, more experienced employees are being shoved aside in favor of more inexperienced ones.
  • The culture within pharma is driving people away, including new hires.
  • More and more meetings are based on ROI, not the voice of the patient.
  • Don’t hire people who want big salaries; hire people who want to be part of an industry that helps patients.
  • CEOs need to realign their company culture.
Is pharma hiring the right people?

SUMMARY:

  • 99 percent of covid-19 deaths in June were among the unvaccinated.
  •  29 percent of Americans said they were unlikely to get vaccinated — up from 24 percent three months earlier.
  • Most workers do not want their own employer to require vaccination, including the vast majority of unvaccinated workers (92%).
  • The authority of state governments to mandate vaccinations is clear — it goes all the way back to a 1905 Supreme Court case.
  • Herd immunity may be impossible because of anti-vaxxers.
Is it time for vaccination mandates?

SUMMARY:

  • Even though the Delta variant of COVID is highly contagious, people are still choosing not to get vaccinated.
  • Concerns about safety, fear of unknown side effects, and misinformation about COVID-19 are some reasons why people may not accept the vaccine.
  • Social media has a lot of health misinformation bet they alone can’t be blamed.
  • The media stories about the FDA. CDC and new drugs have fostered an era of mistrust with some people.
  • DTC marketers need to be more forthcoming when it comes to drug trials and side effects.
What <strong>DTC</strong> marketers can learn from people who refuse a <strong>COVID</strong> vaccination

SUMMARY:

  • The Committee on Oversight and Reform and the Committee on Energy and Commerce is investigating the approval process for Biogen’s new Alzheimer’s drug.
  • Janet Woodcock acknowledged on Wednesday her agency may have misstepped in the handling of its polarizing approval of a new Alzheimer’s drug.
  • Biogen undertook a secret campaign, termed Project Onyx, to persuade FDA to approve Aduhelm.
  • Biogen’s reputation may be damaged beyond repair.
Biogen is in deep trouble and may not survive

SUMMARY:

  • The FDA has many puzzled as to why they approve some drugs with questionable data and ask for more data on other drugs.
  • The FDA approves drugs on the potential to save a life, the cost of the drugs is never considered in the process.
  • The FDA has been under criticism, but an internal investigation will focus on approval processes, not “why” a drug was approved.
  • Our healthcare system cannot continue to support marginally effective drugs. We need to learn to say NO.
  • Drug companies know how to play the system.
Drug companies know how to play the <strong>FDA</strong> drug approval process